在大麻电子商务平台上提出的妇女健康福利索赔的特征:回顾性市场监督研究
Matthew C Nali1, Meng Zhen Larsen1, Zhuoran Li2
1San Diego Supercomputer Center, University of California, San Diego, CA USA; Global Health Policy and Data Institute, San Diego, CA USA; S-3 Research, San Diego, CA USA; Global Health Program Department of Anthropology, University of California, San Diego.
American journal of preventive medicine
|November 8, 2025
概括
尽管存在潜在的生殖风险,但在电子商务网站上发现了超过400种用于妇女健康益处的大麻衍生产品 (CDP). 需要进一步的研究来了解消费者的感知和对行为的影响.
科学领域:
- 生殖健康 生殖健康
- 大麻衍生产品 大麻衍生产品
- 消费者风险评估 消费者风险评估
背景情况:
- 消费者对大麻制品 (CDP) 的兴趣很高,特别是在女性中.
- 了解关于CDPs对女性生殖健康的说法对于评估消费者风险至关重要.
研究的目的:
- 检查大麻衍生产品电子商务列表中的女性生殖健康声明.
- 为了确定宣称的健康益处类型和产品特征.
- 评估健康警告的存在和用户生成的评论.
主要方法:
- 来自Leafly和Weedmaps的美国产品列表的数据挖掘.
- 用关键词过女性健康和生殖主题.
- 关于健康益处,服药途径,警告和评论的CDP列表的内容编码.
主要成果:
- 408个CDP列表在五个妇女健康领域 (月经周期,生育能力,条件,更年期,孕产妇健康) 提出了465个健康益处索赔.
- 最受欢迎的权利要求集中在月经周期的好处 (57.2%).
- 很少有列表 (6.6%) 包含健康免责声明;局部/透皮是最常见的给药途径.
结论:
- 许多大麻衍生产品在电子商务平台上为妇女健康而推广.
- 这些产品的营销尽管存在已知的生殖和孕产妇健康风险.
- 需要进一步调查,以了解消费者对这些营销好处的感知和行为影响.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
657
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
657
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Bioavailability Study Design: Healthy Subjects Versus Patients
137
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
137
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Control Governance: Regulatory Bodies and Their Impact
473
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
473
Analysis of Population Pharmacokinetic Data
659
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
659


